Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Lise J Estcourt(NHS Blood and Transplant), Aaron A.R. Tobian(Johns Hopkins University), Jay S. Raval(Johns Hopkins University), Claire Iannizzi(University of Cologne), Jed B. Gorlin(New York Blood Center), Ralph R. Vassallo(Vitalant), Evan M. Bloch(Johns Hopkins University), Brenda J. Grossman(Washington University in St. Louis), Jeffrey L. Winters(Mayo Clinic), Ruchika Goel(Johns Hopkins University), Todd W. Rice(Vanderbilt University), Claudia S. Cohn(University of Minnesota), Gregory Beaudoin, Farid Foroutan(Ted Rogers Centre for Heart Research), Beth H. Shaz(Duke University), Arturo Casadevall(Johns Hopkins University), Nina Kreuzberger(Gesundheitsamt), Michael J. Joyner(WinnMed), Ryan A. Metcalf(University of Utah), Monica B. Pagano(University of Washington), Elizabeth S. Allen(University of California San Diego), Dana V. Devine(University of British Columbia), Nicole Skoetz(Medical University of Vienna), Thomas J. Gniadek(Johns Hopkins University)
Cited by 71
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
|Nature Reviews Microbiology|2015|1.3k
Balanced Crystalloids versus Saline in Noncritically Ill Adults
|New England Journal of Medicine|2018|1.1k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
|Annals of Internal Medicine|2012|1.1k